Stopping penicillin for early rheumatic heart disease
Part of Heart & circulation, Infections clinical trials.
This trial tests whether it is safe to stop taking daily penicillin for children and teens whose rheumatic heart disease has improved or stayed mild. If you took part in the GOALIE study and your heart condition is now stable, this study may help determine if you can safely stop medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You took part in the earlier GOALIE study
- Your last heart ultrasound showed normal or only mild rheumatic heart disease
- You are between 5 and 20 years old
- You do not have severe rheumatic heart disease
- You have not moved far away from the study center
- You do not have a known penicillin allergy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a vaccine called StreptInCor to see if it's safe and helps the body build immunity against strep bacteria. It may help prevent serious complications like rheumatic fever and heart damage.
This study is testing whether a vaccine can prevent rheumatic heart disease in children. It involves children aged 5 to 8 years who are healthy, live in certain areas, and have no history of heart problems. The study will check children's hearts with an ultrasound and follow them over time.
This study tests whether an antibiotic called azithromycin can help prevent complications and disease progression in young people with rheumatic heart disease (RHD—a type of heart valve damage). You would take this medication monthly and visit the clinic for check-ups to see if it helps protect your heart.
This trial tests a way to safely remove 'penicillin allergy' from your medical records if you have a low-risk history. The goal is to make allergy testing more efficient and free up healthcare resources.
This study tests whether a program in schools can help prevent rheumatic heart disease in children. If your child is between 5 and 16 years old and attends a participating school, they may be able to join.
This study tests if people with a low-risk penicillin allergy can safely have the allergy label removed through a simple risk assessment and testing, without needing a full drug challenge. It aims to help more people get the right antibiotics when needed.
Hear when a new Rheumatic Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.